- Home
- VEEE vs THAR Comparison
VEEE vs THAR Comparison
Compare VEEE & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- THAR
- Stock Information
- Founded
- VEEE 1994
- THAR 2017
- Country
- VEEE United States
- THAR United States
- Employees
- VEEE N/A
- THAR N/A
- Industry
- VEEE Marine Transportation
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- THAR Health Care
- Exchange
- VEEE Nasdaq
- THAR Nasdaq
- Market Cap
- VEEE 5.8M
- THAR 5.5M
- IPO Year
- VEEE 2021
- THAR 2022
- Fundamental
- Price
- VEEE $2.40
- THAR $3.14
- Analyst Decision
- VEEE
- THAR Strong Buy
- Analyst Count
- VEEE 0
- THAR 1
- Target Price
- VEEE N/A
- THAR $17.00
- AVG Volume (30 Days)
- VEEE 4.4M
- THAR 29.4M
- Earning Date
- VEEE 11-13-2025
- THAR 11-06-2025
- Dividend Yield
- VEEE N/A
- THAR N/A
- EPS Growth
- VEEE N/A
- THAR N/A
- EPS
- VEEE N/A
- THAR N/A
- Revenue
- VEEE $13,153,262.00
- THAR N/A
- Revenue This Year
- VEEE N/A
- THAR N/A
- Revenue Next Year
- VEEE N/A
- THAR N/A
- P/E Ratio
- VEEE N/A
- THAR N/A
- Revenue Growth
- VEEE N/A
- THAR N/A
- 52 Week Low
- VEEE $1.86
- THAR $0.95
- 52 Week High
- VEEE $9.30
- THAR $9.08
- Technical
- Relative Strength Index (RSI)
- VEEE 54.11
- THAR 48.05
- Support Level
- VEEE $2.27
- THAR $2.75
- Resistance Level
- VEEE $2.62
- THAR $3.46
- Average True Range (ATR)
- VEEE 0.31
- THAR 1.23
- MACD
- VEEE 0.05
- THAR -0.32
- Stochastic Oscillator
- VEEE 33.75
- THAR 6.16
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.